BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30582215)

  • 1. A new method for excavating feature lncRNA in lung adenocarcinoma based on pathway crosstalk analysis.
    Qi G; Kong W; Mou X; Wang S
    J Cell Biochem; 2019 Jun; 120(6):9034-9046. PubMed ID: 30582215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
    Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
    Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
    Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
    Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of lncRNA expression profiles and identification of functional lncRNAs in lung adenocarcinoma.
    Qiu M; Feng D; Zhang H; Xia W; Xu Y; Wang J; Dong G; Zhang Y; Yin R; Xu L
    Oncotarget; 2016 Mar; 7(13):16012-22. PubMed ID: 26918601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
    Liu B; Chen Y; Yang J
    Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.
    Wang Y; Fu J; Wang Z; Lv Z; Fan Z; Lei T
    Cancer Biomark; 2019; 25(4):313-324. PubMed ID: 31322548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes.
    Wang L; Li J; Zhao H; Hu J; Ping Y; Li F; Lan Y; Xu C; Xiao Y; Li X
    Mol Biosyst; 2016 Mar; 12(3):711-20. PubMed ID: 26725846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
    Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
    Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis.
    Li J; Yu X; Liu Q; Ou S; Li K; Kong Y; Liu H; Ouyang Y; Xu R
    Mol Med Rep; 2019 May; 19(5):4067-4080. PubMed ID: 30896819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes.
    Zhou D; Xie M; He B; Gao Y; Yu Q; He B; Chen Q
    Mol Med Rep; 2017 Oct; 16(4):5129-5136. PubMed ID: 28849055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
    Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
    Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
    Li L; Feng T; Qu J; Feng N; Wang Y; Ma RN; Li X; Zheng ZJ; Yu H; Qian B
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):20-28. PubMed ID: 29297704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNAs in lung cancer: what we know in 2015.
    Xu YJ; Du Y; Fan Y
    Clin Transl Oncol; 2016 Jul; 18(7):660-5. PubMed ID: 26680632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes.
    Yang J; Lin J; Liu T; Chen T; Pan S; Huang W; Li S
    Lung Cancer; 2014 Aug; 85(2):110-5. PubMed ID: 24906504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of lung adenocarcinoma.
    Li L; Peng M; Xue W; Fan Z; Wang T; Lian J; Zhai Y; Lian W; Qin D; Zhao J
    J Transl Med; 2018 Dec; 16(1):372. PubMed ID: 30587197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.
    Ma G; Zhu J; Liu F; Yang Y
    DNA Cell Biol; 2019 Feb; 38(2):176-183. PubMed ID: 30601026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas.
    Yu H; Xu Q; Liu F; Ye X; Wang J; Meng X
    J Thorac Oncol; 2015 Apr; 10(4):645-54. PubMed ID: 25590602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.